Keep Up With McLean!
Receive the latest news in your inbox each month.
Recent advances in computing now allow us to measure aspects of behavior and physiology that would not have been feasible even a handful of years ago. This panel showcases some examples of cutting edge tools for understanding the brain and behavior that are low cost and scalable, towards a future of “digital diagnostics” that can be leveraged to increase the accessibility and impact of mental health services.
This talk was part of the panel Digital Diagnostics: Leveraging Technology to Enhance Mental Health Assessment. 2017 Technology in Psychiatry Summit, was sponsored by the McLean Institute for Technology in Psychiatry on November 6-7, 2017, at the JB Martin Conference Center, Harvard Medical School.
Armen C. Arevian, MD, PhD, is the director of the Innovation Lab at the UCLA Semel Institute for Neuroscience and Human Behavior. His work involves “participatory informatics,” combining neuroscience, psychiatry, participatory research, and informatics to support research and health system innovation that is translational and transdiagnostic while seeking to address equity and disparities in vulnerable populations. Examples include utilizing speech as a behavioral biomarker in serious mental illness, and Chorus, a web platform that enables individuals without technical expertise (i.e., patients, community leaders) to co-create their own mobile apps based on their needs/priorities, and then use them in real-time.
Please visit mclean.org/itp to learn more about the McLean Institute for Technology in Psychiatry.
Back to top